Trouble for Jardiance

Discussion in 'Boehringer Ingelheim' started by anonymous, Aug 3, 2017 at 10:46 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Jardiance dropped from CVS formulary in favor of Invokana. That one is going to hurt. Anyone volunteer to tell Germany, or are we going to withhold that information from them like everything else?
     

  2. anonymous

    anonymous Guest

    I know. Nottthhhhing!
     
  3. Looks like malpractice on the part of CVS!
     
  4. anonymous

    anonymous Guest

    Ever time I see the lawyer ads on tv I wonder how long until they go after an insurance company. I wonder if some lawyer will go after Caremark if a patient suffers an amputation or CV death while on Inbokana rather than Jardiance.
     
  5. anonymous

    anonymous Guest

    Heeehehe that's a good one
     
  6. anonymous

    anonymous Guest

    I'm on Invokana and quite frankly, I'm stumped.

    (Get it? Stumped? Amputation joke. Rim shot. Hi yo!)
     
  7. anonymous

    anonymous Guest

    What it means is that budget will be dropped by several hundred million $$ next year so we can be at 100% target and think the company is doing great.
     
  8. anonymous

    anonymous Guest

    They won't pay IC on tradjenta which will be at 145% and Jardiance will be at 87% so small to no commissions for that but they will say diabetes over 100% to goal